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ABSTRACT 
Tuberculosis has been considered an occupational risk for health care workers 
since the 1930s. Over the past six decades, however, TB incidence and TB infection rates 
have dramatically decreased. This decline has been largely due to improved living 
conditions, nutrition and pharmaceutical treatment. Today, opinions about TB risk in the 
health care settings vary considerably and include the view that health workers are at no 
increased risk for TB infection compared to the general population. 
TB screening programs have been operating in British Columbia long-term care 
facilities (LTCFs) since 1987. The primary interest ofthese programs has been to monitor 
the risk that employees of these health care facilities have. The purpose of this thesis is to 
evaluate these screening programs based on the following questions: 
1. Is the TB incidence ofLTCF employees higher than that ofthe general 
.': : 
population who are similar in age, gender and ethnic origins? 
2. Is TB infection rate ofLTCF employees higher than that found in 
similar studies in other jurisdictions? 
. ' 
3. What are the costs of the screening program and how do these costs compare 
with the costs of treating active TB cases that would have occurred if the 
screening program had not been in place? 
Analyses of the B. C. TB Control five year data has revealed that TB incidence of 
L TCF employees is not greater than the general population when age, gender and ethnic 
origin are controlled. An analysis of TB incidence rate by each ethnic group (immigrants, 
First Nations and other Canadians), revealed that the TB incidence rate in immigrants and 
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First Nations are 6 and 53 times, respectively, higher than Canadian born. Further, the TB 
incidence in each ethnic group is consistent with its corresponding population. These 
results suggest that TB is more related to birthplace than to working place. 
The TB infection rate (21.9%) in British Columbia long-term care facility 
employees found in this study is in the mid-range of studies in other jurisdictions. When 
analysis was performed in each ethnic group, it was found that the infection rate in 
immigrants (52.3%, 95% CI is 3.23-3 .58) and First Nations (46.3%, 95% CI is 2.49-3 .61) 
are much higher than Canadian born (10.6%). However, the TB infection rate in adult care 
facility employees (24.6%) is not greater (95% CI is 0.87-1.0) than that of child care 
facility employees (17. 6%) after adjusting for age, gender and ethnic origin. TB infection 
rate is al~.o more related to birthplace than to the working place. 
INH preventive therapy is provided to those who are found to be PPD positive to 
prevent the occurrence of active TB from TB infection. It was calculated that the cost of 
preventing of one TB case ($58,272) is much higher than the treatment of active TB 
($10,304). From this perspective, this program should be stopped. However, considering 
the high TB infection rate in immigrants and First Nations, the TB screening program 
should target to these high risk groups to prevent the potential reactivation ofTB. 
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CHAPTER I 
TUBERCULOSIS: A BACKGROUND 
This chapter provides a basic introduction to the disease that is called tuberculosis. 
It covers, briefly and in non technical language, the etiology of the disease, its 
transmission, BCG vaccination, antibiotic chemotherapy, tuberculin skin testing and 
chemoprophylaxis. 
Introduction 
Tuberculosis (TB) is an ancient disease that was a scourge of humankind in many 
parts of the world. It has remained so in economically underdeveloped countries. TB is 
also referred to as mycobacterium tuberculosis (M tuberculosis) since almost all causes of 
TB are now due to M tuberculosis. The infection by M tuberculosis occurs through 
inhalation of the tubercle bacillus which is dispersed through the air by sneezing, coughing, 
and talking of infectious TB patients. After the tubercle bacillus invades the human body, 
it can reside in most organs of the body and cause various kinds of TB. If the tubercle 
bacilli site is in the lungs and bronchi, it is referred to as pulmonary TB, representing 85% 
of all kinds of TB. Pulmonary TB is more infectious than other kinds of TB (Canadian 
Thoracic Society [CTS], 1996). If the site is in an organ other than the lungs or bronchi, it 
is referred to as extra-pulmonary TB. Thus, extra-pulmonary TB includes lymphatic TB, 
pleural TB, genitourinary TB, bone and joint TB, and tuberculous meningitis. 
TB Infection and Active TB 
When considering TB, it ts important to distinguish between the concept of 
infection and disease. TB infection is the state in which the tubercle bacillus has become 
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established in the body. The infected individual has no symptoms, signs, nor 
roentgenographic abnormalities suggestive of TB, and bacteriologic studies are negative. 
On the other hand, TB disease is classified as clinical TB, a state in which an infected 
individual has an illness involving one or more organs of the body. The patient has 
symptoms and signs of active TB, abnormal roentgenograms, and positive bacteriologic 
studies (Table 1 ). Infection is usually defined by tuberculin skin test reactivity. Diagnosis 
Table 1 
Features Distinguishing Tuberculosis Infection from Pulmonary Tuberculosis Disease 
Features 
Similarities: 
Tuberculosis organisms present in the body 
Tuberculin skin test usually positive 
Differences: 
Chest X-ray 
Specimens for mycobacteria 
(smears or cultures) 
Symptoms 
TB Infection 
Yes 
Yes 
Normal 
Negative 
None 
Yes 
Yes 
TB Disease 
Abnormal 
Positive 
Cough, fever, night sweats, 
weight loss 
Infectious No Often, before treatment 
A "case" of TB No Yes 
Note. From 'Tuberculosis Comeback: Impact on Long-Term Care Facilities", by 
Lancaster, E., 1993, Journal ofGerontological Nursing, 7, p. 18. 
of TB disease is usually established by finding mycobacteria on a smear or culture of 
appropriate body fluids . Smears of appropriate specimens for detection of mycobacteria 
are currently the fastest and easiest methods for early presumptive diagnosis of TB, but 
they are less sensitive and specific compared to cultures. Cultures are the definitive 
method for diagnosis of TB, but the testing process may take as long as 6 weeks. 
Transmission of TB 
TB is transmitted by airborne infection. When a source case coughs, sneezes, 
laughs, speaks, or sings, the aerosolized respiratory excretions are expelled from the nose 
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or mouth, and their water content evaporates rapidly leaving only a small residue of solid 
matter, the droplet nucleus, that includes the tubercle bacillus. The droplet nuclei reach the 
alveoli and may cause infection. The occurrence of infection depends on many factors. 
These factors are grouped and summarized in Table 2. 
Table 2 
Factors Influencing Transmission ofTuberculosis 
1. Source case 
a. Pulmonary versus non-pulmonary 
b. Extent of pulmonary disease 
c. Severity of cough 
d. Chemotherapy 
2. Environmental factors & Circumstances of the exposure 
a. Concentration of organisms in the air 
b. Ultraviolet irradiation 
c. Proximity 
d. Duration 
3. Host factors 
a. Previous tuberculosis infection 
b. Previous infection with nontuberculous mycobacteria 
c. Vaccination with Calmette-Guerin bacillus (BCG) 
d. Other clinical diseases which reduce cell-mediated immune system 
Note. From 'Textbook of Respiratory Medicine (p. 864)': by Murray, J. F.& 
Nadel, J. A. , 1988, Philadelphia: Saunders Company. 
TB transmission is defined as the mechanical act of transfer of M tuberculosis 
from the source case to a potential new host. It depends on three conditions which are: the 
number of mycobacteria the source case produces; the environment shared with source 
case; and the host ' s resistance to mycobacterium infection. 
The number of mycobacteria produced by the source case is the first factor that 
affects TB infection. If both the environment shared with source cases and the host's 
resistance are constant, a greater number of bacteria produced by the source case will 
increase the chance that the contacts will get infected. TB patients who have untreated 
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pulmonary TB and smear positive sputum transmit infection with significant frequency 
(CTS, 1996). However, individuals with TB infection and most TB patients do not 
produce a significant number of tubercle bacilli, they are not considered infectious 
(ATS/CDC, 1990). 
The second condition that affects transmission is the environment shared with the 
source case. The conditions under which the exposure occurs determine, in part, the 
number of infectious particles inhaled. If the exposure is of long duration, and takes place 
under conditions that would be associated with a high concentration of droplet nuclei in 
the air, the likelihood that transmission will occur will be greater. However, in good living 
conditions, infection is unlikely to occur due to the dilution of infected air by ventilation, 
reducing the survival rate of most tubercle bacilli from the source case. It has been 
reported that improved living conditions were a major factor in the steady decrease of TB 
incidence and mortality long before antibiotic drugs were discovered (Grygier et al, 1994). 
The third condition that determines TB transmission is the immune status of the 
host. In most individuals, the immune status is strong enough that most do not develop 
active disease when exposed. Further, both BCG vaccination and previous mycobacteria 
infection may increase the immune response, affording some protection against subsequent 
infection with M tuberculosis (Koch-Weser, 1985; Palmer, 1966). But, other factors such 
as advancing age, malnutrition, diabetes, or HIV infection may cause defects in the cell-
mediated immunity, increasing the risk of infection. 
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BCG Vaccine 
The anti-tuberculosis vaccine is a suspension of live tubercle bacilli (M bovis) that 
have been attenuated by laboratory cultivation on a special medium. This method was 
developed by Drs. Albert Calmette and Camille Guerin of France in 1920. To 
commemorate these two doctors, this vaccine is referred to as BCG (Bacilli Calmette-
Guerin) vaccine. Evidence has suggested that BCG vaccination will result in a 60-80% 
decrease in the incidence of TB in a given population (Leulmo, 1982). It is also clear that 
the role of BCG is not to prevent infection, but rather to increase the host's resistance, 
limiting the proliferation of tubercle bacillus to such a degree that clinical disease does not 
develop (Sutherland et al, 1979). However, since antibiotic chemotherapy has been 
administered to active TB patients, exogenous infection occurs infrequently, and TB 
incidence has dropped dramatically. Hence, BCG is no longer routinely used in the general 
population of developed countries. 
Further, BCG vaccine can cause a false-positive reaction to the tuberculin skin test 
and the circumstances under which these reactions occur is detailed below in the section 
headed "The Tuberculin Skin Test". 
However, BCG is still recommended for the general population of developing 
countries by the World Health Organization (WHO) (WHO, 1982), since TB infection and 
incidence rates are still high in those countries. 
Antibiotic Chemotherapy 
While BCG vaccine is used to increase the host ' s resistance to TB infection, 
antibiotic chemotherapy is used to kill the mycobacteria in the source case. When the drug 
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streptomycin (STM) was discovered, the treatment of active TB underwent a 
revolutionary change and, with the advent of even more effective drugs such as isoniazid 
(INH) and rifampin (RMP), the great majority of patients can be cured. 
Definition of TB Prevalence. Incidence and Mortality 
The measures of disease frequency used most frequently in epidemiology fall into 
two broad categories: prevalence and incidence. The prevalence of TB is calculated as the 
total number of TB patients in a defined population at a given point in time, divided by the 
total population investigated. On the other hand, TB incidence is defined as the number of 
new cases of TB that occur or are found during a specified period of time (annually in 
general), divided by the total population at risk. 
TB mortality is calculated as the total number of deaths because of TB disease, 
divided by the total population investigated. 
The Epidemiology of TB 
At the beginning of this century, TB disease was the leading cause of death in the 
western world ('Canadian Discoveries", 1984). The most susceptible population was 
infants and young adults (Springett, 1952). But this mortality pattern has changed because 
of many factors which include improved living conditions, BCG vaccination, the 
availability of chest X-ray surveys, and the use of antibiotic chemotherapy in active cases. 
In Canada, the annual rate of new and reactivated cases of TB has dropped from 
80/1 00,000 in 193 8 to 7. 111 00,000 in 1994. The mortality rate has declined from 
551100,000 to 0.4/100,000 in the same time period (Statistics Canada, 1996) (Figure 1). 
Not only has the incidence of TB decreased, but the population at risk has also changed. 
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Nowadays, this disease is largely found among seniors, First Nations, immigrants from 
areas with a high prevalence of TB, and socio-economically disadvantaged individuals 
(Canadian Thoracic Society [CTS], 1996). 
The Tuberculin Skin Test 
Although TB incidence and mortality rates have decreased dramatically, there 
continues to be a need to identify individuals with TB infection as candidates for INH 
preventive therapy, so that occurrence of active TB may be prevented. The tuberculin skin 
test has been adopted as a screening test. 
Tuberculin (an impure extract derived from a culture broth in which tubercle bacilli 
had been grown) was first prepared by Koch in 1890 and he advocated its use for 
therapeutic purposes (Keers, 1978). However, it was later found that the reaction to 
tuberculin was of diagnostic rather than therapeutic importance. In 1934, Seibert made a 
simple protein precipitate of crude tuberculin, which she termed purified protein derivative 
(PPD). This purified preparation has become the preferred reagent for diagnostic purpose 
in most areas of the world and the current tuberculin skin test is also referred to as the 
PPD test. 
Based on vanous studies of sanatorium patients and of large non-infected 
populations, Edward et al (1960) and Lester et al (1958) reported that the non-infected 
populations demonstrated a 0-5 mm induration in response to the PPD test and the 
sanatorium patients had a mean value of 16- to 17 -mm reaction. Initially the accepted 
standard for the lower limit of a positive reaction was an induration of 5 mm (Lester et al, 
1958). However, it was found that in many tropical climates, large segments of the 
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populations had skin test hypersensitivity to environmental mycobacteria (nontuberculous 
mycobacteria), producing cross-reactions with PPD manifested by small-sized tuberculin 
reactions (4-12 mm) (Edward et al, 1960). Recognition of the cross-reaction between 
antigens ofnontuberculous mycobacteria led the American Thoracic Society (ATS, 1971) 
to recommend the adoption of 1 0 mm as the minimal size of induration defining a positive 
tuberculin skin test. 
It should be noted that the tuberculin skin test is only an indicator of infection with 
tubercle bacilli. Both false-positive and false-negative reactions are encountered 
frequently . 
BCG vaccination and nontuberculous mycobacterium infection are two maJor 
factors that cause false-positive PPD reactions. Menzies (1992) reported that, when BCG 
is given in infancy, it does not affect PPD reaction. However, for those vaccinated 
between 6 and 14 years, up to 25% had reactions larger than 10 mm without TB infection. 
A false-positive reaction may also be caused by nontuberculous mycobacterium infection 
(Grzybowski, 1974) since individuals with nontuberculous mycobacteria infection can 
produce cross-reactions with PPD. 
Many factors may cause false-negative reactions. Age has been considered to be a 
problem in PPD testing for many years. Stead (1987) reported that today' s elderly had an 
infection rate of80% in the 1930s when they were younger, but only 20-30% ofthem test 
positive today. Although the reason is not clearly understood, it is thought that the cell-
mediated immune system is decreased in the elderly, so that the positive reactions may not 
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be reflected in the tuberculin skin tests. Hence, PPD testing is not recommended for 
screening an elderly population. 
Some disease states that interfere with cell-mediated immune responses also cause 
a false-negative reaction. Common viral illnesses such as measles and the administration of 
live virus vaccines may cause a transient depression of tuberculin reactivity. 
Corticosteroids and immuno-suppressive drugs decrease tuberculin reactivity if the patient 
is on a sufficient dose for a long enough period of time (Bovornkitti, 1960). Malnutrition 
may cause defects in cell-mediated immunity. Further, advanced tuberculosis itself may 
cause diminished or absent tuberculin responsiveness. Finally, HIV infection may 
compromise the cell-mediated immune system and cause a false-negative reaction. It has 
been reported that 20% -30% of persons with known active TB without HIV infection 
and as many as 60% of persons with HIV infection have a false-negative reaction (Centre 
for Disease Control [CDC], 1990). 
Although the tuberculin skin test is an imprecise diagnostic instrument, no better 
test has been developed. Recent developments in mycobacteriology based on radiometric 
methods and genetic probes specific for mycobacterial species may speed up the diagnosis 
ofTB, but these methods have not been routinely used (CTS, 1996). 
INH Chemoprophylaxis 
Chemoprophylaxis, administered as the outcome of the tuberculin skin test, is 
defined by Hoeprich (1972) as a form of treatment for an infection which has not yet 
occurred, for an infection in the beginning stage, or for an asymptomatic subclinical state. 
Chemoprophylaxis is also referred to as preventive therapy. 
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The effectiveness of INH preventive therapy was first demonstrated by Ferebee 
and Mount (1962). Subsequent to this discovery, many clinical trials were performed in 
different countries. The protection rate of INH has been found to be between 60% and 
100% (CTS, 1996). These results have contributed towards the goal 'to eradicate TB by 
the year of 201 0" (CDC, 1989). Nevertheless, side effects of INH have been identified and 
the use of INH preventive therapy has become limited by the counteraction of these 
effects. 
Side Effects of INH. A serious side-effect of INH therapy is INH associated 
hepatitis or INH induced hepatitis. The United States Public Health Service (USPHS) 
reported the possibility of hepatitis in patients receiving INH as 1 per 100,000 under the 
age of 20; 300 between ages 20 and 35; 1,200 between ages 35 and 49; and 2,300 
between ages 50 and 64 (Kopanoff et al, 1978). For those aged 64 years or older, the rate 
has been documented as 5,000/100,000 (Dutt et al, 1993). These results are summarized 
in Table 3. 
Table 3 
USPHS Study Recorded Possibility OfHepatitis 
Age (yr.) Hepatitis Risk 
<20 rare 
20-34 0.3% 
35-49 1.2% 
50-64 2.3% 
>=65 5.0% 
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Because INH associated hepatitis increases with age, the use of INH preventive 
therapy in the elderly is limited. This incorporated in ATS/CDC guidelines for INH 
preventive therapy (ATS/CDC, 1986). 
Other side effects are less serious but more common. These include erythematous 
itchy rash, mental lethargy, arthralgia, peripheral neuropathy and optic neuritis. Although 
INH has not been found to be teratogenic, it is not routinely recommended for pregnant 
women, except for those who are IDV positive (CTS, 1996). 
Candidates for INH Preventive Therapy. Balancing the risk of hepatic injury during 
the period of treatment and the potential lifelong benefit of preventive therapy, INH 
preventive therapy is recommended for (ATS/CDC, 1986): (a) individuals who are less 
than 3 5 years of age and have PPD positive reactions; and (b) individuals who are older 
than 3 5 with PPD positive reactions and have other risk factors which increase the risk of 
developing active TB. These risk factors include: 
• close contacts 
• newly infected persons or convertors 
• past TB which has not been previously treated with adequate chemotherapy 
• abnormal chest roentgenograms 
• AIDSIHIV status 
• other clinical conditions such as silicosis, diabetes mellitus, immunosuppressive 
therapy, and other conditions associated with substantial rapid weight loss or 
chronic undernutrition 
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illY Infection and TB Disease 
Since illY infection seriously compromises the immune system, especially the cell-
mediated immune system, TB disease is unusually high in the illY positive population. In 
1990, it was found in the United States that 4.3% of 152,441 AIDS cases were infected 
with TB. The results of illV serological prevalence surveys in metropolitan TB clinics 
have shown that 11% of TB cases have illY serological positive reactions (ATS, 1992). It 
is also indicated that, in the United States, from the 1950s to 1984, the rate of TB 
incidence was declining by 5 to 7% annually. However, from 1985 to 1991 the number of 
cases increased by 18%. The occurrence of TB among persons with illY infection is a 
major factor contributing to this change in the decades-long pattern of decline in TB. 
In Africa, the situation is even worse. By the end of 1993, 301,861 cases of AIDS, 
or 36% of the global total, had been officially reported to the World Health Organization 
(WHO) from Africa, a continent with less than 10% of the world ' s population (WHO, 
1994). TB has become the greatest AIDS-related opportunistic infection. An autopsy 
study in Abidjan (Lucas, 1993) showed that TB was the cause of death in 32% of 247 
illY-positive patients. In Rwanda, among 370 illY-positive patients surveyed, 22 (15%) 
were diagnosed as having active TB (Anglaret et al, 1995). Wilkinson and Moore (1995) 
investigated 297 patients diagnosed with TB in a rural district hospital in South Africa, 
and found that 107 (36%) were illY positive. In these countries, the treatment of TB in 
illV positive patients is not stressed because of the limited resources. As Reeve ( 1994, p 
416) said, 'HIV remains a terminal illness and the palliative treatment of illV -related 
conditions must remain a low priority in African countries with limited health budgets." As 
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a result, AIDS and related TB disease cause greatly increased adult mortality, reduced life 
expectancy, disrupted families, excessive demands on health care facilities, and reduced 
economic output (De Dock, 1994). 
In Canada, there has been no evidence that the lilY epidemic has had a substantial 
impact on overall TB incidence rates. According to British Columbia data, less than 2% of 
TB cases are associated with lilY infection (CTS, 1996). However, with increasing 
number oflilY infections and AIDS, TB may be resurrected all over the world. This new 
trend poses a new problem for controlling TB disease. 
CHAPTER II 
TUBERCULOSIS IN BRITISH COLUMBIA 
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This chapter briefly reviews the history of the treatment of active TB, chest X-ray 
surveys and the tuberculin skin tests in British Columbia. A comparison of current TB 
status is made between general population and residential care in British Columbia. 
The Tranquille Tuberculosis Society 
In 1904, the Tranquille Tuberculosis Society was formed for the prevention and 
treatment of consumption, and the first sanatorium was built at Tranquille near Kamloops, 
British Columbia. Treatment of patients was based on rest, fresh air, exercise and good 
nutrition. In the beginning, this was a voluntary society. However, veterans returning from 
World War I increased the numbers of TB cases and strained the financial resources of the 
voluntary society. As a result, the management of Tranquille Sanatorium was taken over 
by the British Columbia government in 1919. Simultaneously, small scale clinical treatment 
of TB began in Vancouver. 
The Division of British Columbia Tuberculosis Control, Ministry ofHealth 
In 1935, the Division of British Columbia Tuberculosis Control of the Ministry of 
Health was established in Vancouver and the Tranquille TB Society was reorganized and 
moved to Vancouver to assist the new Division in terms of fund raising and public 
education (Ministry ofHealth, 1991). In the 1930s, British Columbia introduced assistance 
programs which were modeled after the province of Saskatchewan's free TB treatment 
program. In 1948, the federal government funded, through the National Health Grants 
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Act, the provision of free treatment of TB (Grygier, 1994). This led to the establishment 
of new sanatoria. In 1949 and 1952, two more sanatoria, Willow Chest Centre (WCC) and 
Pearson Hospital, were opened in Vancouver. At this time, sanatorium bed capacity 
reached its peak and subsequently the number ofbeds started to decrease (Table 4). 
Table 4 
Sanatorium population in British Columbia 
Year Total population in British Columbia sanatoria 
1952 838 
1955 615 
1958 332 
1961 244 
1963 205 
1964 163 
Note. From '~nual Report", by The Division of Tuberculosis Control, Province 
ofBritish Columbia, 1965. 
Over the 13 year period between 1952 and 1964 (corresponding roughly to the era 
of introduction of chemotherapy), the British Columbia sanatorium population dropped by 
over 500%. By 1958, Tranquille Sanatorium was closed and tuberculosis beds became 
centralized in the Vancouver area at the WCC, at the Pearson Hospital, and at the 
Essondale Mental Health Facility. This symbolized the transition of treatment from rural 
isolation to an urban general hospital setting. 
As the bed capacity of sanatoria decreased, the efforts switched from passive 
treatment to active case-finding. In 1957, the Division of British Columbia TB Control 
launched a chest X-ray examination program across the province. Many early stage and 
asymptomatic patients were picked up in this campaign. This campaign was discontinued 
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m 1965 since community surveys were found to be no longer productive (Division of 
Tuberculosis Control, 1971 ). 
As a result, the tuberculosis treatment facilities were closed or their functions 
changed. In 1964, operating rooms at the WCC were converted from TB surgical units to 
cardiac units and, in the same year, the full-time tuberculosis specialist stationed at 
Essondale was released. In 1996, the only chest clinics of the Division of TB Control 
across the province are located in WCC, New Westminster and Victoria, and only WCC 
provides in-patient services. 
Tuberculosis Chemotherapy in British Columbia 
By the mid-60s, tuberculosis treatment had become centralized in Vancouver and 
relied mainly on 18-24 month daily combination therapy (INH and p-aminosalicylic acid 
[PAS]). Patients remained in hospital for most of their treatment. This hospitalized drug 
therapy remained the treatment of choice until the 1970s. By the 1970s, RMP was 
recognized to be equally as effective as INH. Subsequently, RMP and INH short course 
daily chemotherapy were introduced as the out-patient treatment of choice at the wee, 
replacing the long-course methods. In the 1970s, the WCC shifted from an in-patient 
centre for tuberculosis treatment to a mainly out-patient based treatment system. After 
1979, RMP, INH and ethambutol short-course therapy administered for an average of 9 
months became the standard treatment at the wee. 
Tuberculosis screening program for the high risk groups 
Chest X-ray screening programs for TB were introduced in British Columbia as 
early as 1921 to screen First Nations populations. In 1944, X-ray examinations were 
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initiated as a screening method to identify active TB in Canadian immigrant applicants. In 
1957, chest X-ray surveys were introduced for the general population. The purpose of 
these programs was to find active TB patients. Many asymptomatic TB patients were 
picked up in these programs and were treated with chemotherapy. Hence, TB incidence 
and infection rates decreased dramatically. 
Current screening programs, introduced in the 1980s, use the tuberculin skin test. 
The use of the tuberculin skin test is based on the assumption that TB incidence and 
infection rates have decreased dramatically and the reactivation of early TB infection is the 
major cause of active TB. The major goal of this program is to identify individuals with 
TB infection, following which INH preventive therapy can be administered to prevent 
occurrence of active TB. The tuberculin skin test screening program is directed toward the 
populations at higher risk to contract TB than the general population. These populations 
include {CTS, 1996): 
• close contacts of individuals with known or suspected active TB 
• persons with a history of active TB, or with a chest X-ray suggestive of past TB, 
who have not received adequate therapy 
• persons who are HIV positive 
• foreign-born persons from areas with a high prevalence of tuberculosis 
• aboriginal communities with high rates of tuberculosis 
• the poor, especially the urban homeless 
• alcoholics and intravenous drug users 
• staff and residents oflong-term institutions -- e.g., nursing homes, correctional 
facilities, and psychiatric institutions 
• those with high-risk medical conditions, including chronic renal failure, diabetes 
mellitus, immunosuppressive therapy, and silicosis 
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• those at risk of occupational exposure to TB likely to be exposed to active cases 
of pulmonary tuberculosis. This includes health care workers 
• those at risk of active TB who are employed in settings where they may infect 
infants, children, adolescents or the immunosuppressed 
A tuberculin skin test screening program was initiated in British Columbia long-
term care facilities (LTCFs) in 1987, concurrent with the publication of ATS/CDC 
guidelines of the TB screening program (ATS/CDC, 1986). However, this program has 
been questioned in recent years. In his presentation as the Director of TB Control to the 
99th Meeting of Health Officers' Council of British Columbia, Allen ( 1994) reported that 
TB incidence in residential care and correctional centres is not significantly greater than in 
the general population (Table 5). He suggested that the screening program may not 
ultimately be more efficient than passive case-finding since, although it may find cases 
earlier, the screening program is not likely to be justifiable as a case-finding procedure. 
Table 5 
The Comparison of TB Incidence Between Institutional And General Population 
Year Number of Number of Incidence Incidence of general 
Surveyed active TB (1 /1 00,000) population (1/100,000) 
1990 16,519 2 12.1 9.0 
1991 16,717 1 6.0 8.6 
1992 15,891 2 12.6 10.1 
Total 49,127 5 10.2 9.2 
Note. From "Preliminary Analysis ofRoutine TB Screening Program, British Columbia 
(1990-1992)", by Allen, E. A. , 1995. 
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Given this background, a more detailed study of the TB infection and incidence in 
British Columbia LTCFs is conducted as the basis for this thesis, and the objectives and 
methods are described in Chapter V. 
CHAPTER III 
TB SCREENING PROGRAMS IN LONG-TERM CARE FACILITIES 
IN BRITISH COLUMBIA 
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According to the British Columbia Tuberculosis Screening Guidelines (Ministry of 
Health, 1992), all persons admitted to a licensed community care facility and all new 
employees of licensed community care facilities should be screened for tuberculosis. 
Chest X-rays are administered to all newly admitted residents over the age of 60 to 
exclude active TB. The tuberculin skin test screening program is utilized for the residents 
who are under the age of 60 and all newly employed staff The tuberculin skin test 
screening program is a three step process: 
(1) Tuberculin skin testing: A tuberculin skin test is the intracutaneous injection of 
5 TU PPD (equivalent to 0.0001 mg ofPPD protein contained in 0.1 rnl of solution) in the 
volar surface of the forearm. The reaction is read 48-72 hours subsequent to the injection. 
A positive test is usually defined as greater than 10 mm of induration (erythema is not 
considered), 5-9 mm of induration is considered suspicious, and less than 5 mm is 
considered negative. 
(2) Chest X-rays: Chest X-rays are given to those who have more than 10 mm 
reactions. The purpose of the chest X-rays is to exclude active TB and to provide the 
baseline for chemoprophylaxis. 
(3) INH chemoprophylaxis: INH chemoprophylaxis is not mandatory for all the 
positive PPD reactions. According to Allen (1988), the Director of British Columbia TB 
t 
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Control, patients meeting the indications for chemoprophylaxis (ATS/CDC, 1986) should 
be encouraged to accept this measure. However, the compliance and completion of the 
course should be taken into account. It is recommended : 
• a 12 month treatment duration should be targeted. If there are problems with 
attitude or compliance or adverse effects, minimum 6 month treatment is 
recommended 
• follow-up clinical visits must be made at least monthly 
• biochemical monitoring: transaminase levels and close clinical monitoring are 
required each month for at least the first 3 months 
After the initial screening test is done, routine re-testing of residents/employees is 
not carried out unless there are specific indications in an individual (e.g., abnormal chest 
X-rays compatible with tuberculosis) and specific local situations (e.g., institutions with 
high TB incidence and infection rate). 
The screening model that has been described above is depicted in Figure 2. 
The purpose of this study is to evaluate the tuberculin skin test screening program 
in L TCF employees. The specific purposes include the identification of TB incidence and 
infection rates, the determination of the unit cost of those with positive tuberculin tests 
who are recommended for INH preventive therapy, the determination of the cost of 
providing INH preventive therapy for preventing occurrence of active TB, and the 
comparison of those costs to the treatment of active TB cases. The time period of this 
study is from January 1, 1990 to December 31 , 1994. The methods of this study is 
discussed in Chapter V. 
Chest X-ray 
INH preventive 
therapy 
TB prevented 
NoiNH 
preventive therapy 
No active TB 
INHinduced 
hepatitis 
Figure 2: The model of a tuberculin skin test screening program 
No further action 
required 
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CHAPTER IV 
LITERATURE REVIEW 
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This literature review focuses on studies of TB in elderly population, especially the 
elderly living in long-term care facilities and health care employees in various health 
settings. 
TB in Long-Term Care Facility Residents 
In Chapter I, it was observed that the present-day elderly lived in a time when 
more than 80% of persons were infected with TB. Some elderly individuals continue to 
harbor viable bacilli in dormant caseous and calcified lesions, and the cell-mediated 
immune status of the elderly decreases with age. Hence, persons with old dormant lesions 
may undergo reactivation of infection and become infectious. Approximately 95% of 
active TB in the elderly comes from reactivation of remote infection (Stead, 1967). 
Several factors may predispose the reactivation of dormant lesions in the elderly. These 
include insulin-dependent diabetes, poor nutrition, long-term corticosteroid therapy, and 
other debilitating diseases (Dutt et al, 1993). Further, persons who were never infected or 
who have outlived their bacilli may become infected because of reduced cell-mediated 
immune status. As a result, the elderly have a higher TB incidence rate than any other age 
group. 
The elderly who live in long-term care facilities (LTCFs) may have greater TB 
incidence than those who live in the community. Residents in long-term care institutions 
I 
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are less healthy and older, and live closer than community dwellers and, hence, have 
greater chance of reactivation of infection or re-infection. 
TB in older persons has characteristics that make it more difficult to diagnose than 
in younger persons. Pulmonary TB commonly presents with symptoms of fever, weight 
loss, cough, sputum, and debility. The latter four symptoms may occur in the elderly 
without inciting significant apprehension, either in the patient or in the physician. They can 
be explained by a variety of medical problems commonly encountered in the geriatric 
population or they may simply be dismissed as part of aging. An abnormality observed on 
a chest film may not be properly interpreted because of atypical roentgenograms. Further, 
the overall decline in TB has resulted in a low index of suspicion among physicians. All 
these factors may delay the diagnosis of TB in the elderly. Thus, the chance of TB 
transmission may be increased. 
Studies have shown that TB incidence in the elderly living in LTCFs is higher than 
the elderly living in communities ('Tuberculosis--North Dakota", 1979; 'Tuberculosis--
Oklahoma", 1980), but this was not considered a serious problem until Stead' s widely 
circulated seminal description of two outbreaks in Arkansas nursing homes (Stead, 1979, 
1981 ). The first outbreak (Stead, 1979) was in a 230-bed facility where the index case was 
a patient who had cavitary TB which had been misdiagnosed as lung cancer. Of the 172 
residents at risk, 49 (28%) became strongly positive to PPD and three active cases 
developed among these residents. Five members of the staff also converted. The second 
outbreak was in a 240-bed nursing home in Arkansas (Stead, 1981 ). Results of the 
investigation showed that the index case was a patient who had unrecognized TB for at 
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least 12 months. Forty-nine (30%) of 161 previously PPD negative residents became 
infected and eight ( 17%) acquired progressive primary TB. Of the employee group, 21 of 
138 (15%) converted and one case of clinical TB occurred. 
In the United States, the national data show that approximately 5% of persons 
over age 65 reside in nursing homes but account for 20% of the cases of TB, giving a case 
rate that is 4 times greater than that of elderly persons residing elsewhere (Stead, 1989). In 
Arkansas, 50% of all cases of TB reported from 1981 to 1983 were in persons over 65 
years of age, an incidence of about 60/100,000. In nursing home residents, a reported 
incidence of 234/100,000 is four times greater than that of persons over 65 residing at 
home (Stead, 1985). 
In a recent CDC sponsored survey from 29 states, the difference in TB incidence 
between community and LTCF elderly has declined (Hutton, 1993). Of 15,379 TB cases 
reported, 8% of the 4\919 cases among the elderly occurred among the elderly living in 
nursing homes. The incidence of TB among nursing home residents was 39.2/100,000 
person years, whereas the incidence of TB among elderly persons living in the community 
was 21.5/100,000. The elderly living in the LTCFs has 1.8 times greater TB incidence than 
other elderly. These results, however, did not take into account confounding variables 
such as age, gender and ethnic origins. 
Canadian studies have indicated that L TCF residents are not at an increased risk to 
contract active TB. MacArthur ( 1992) compared the TB incidence in the institutional 
elderly (30.6/100,000) with community dwellers (25 .2/100,000) in the province of Alberta 
after controlling for confounding variables (age, gender and ethnic origins). He concluded 
... i 
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that the LTCF elderly are not at increased risk of tuberculosis (RR = 1.22, 95% 
confidence interval is [0 .74-1.70]). A ten-year retrospective survey in the province of 
Saskatchewan also reported no increase in tuberculosis incidence among the elderly in 
chronic care homes (Hoeppner, 1987). In Canada, the national data for 1993 indicated 
that TB incidence in the elderly is 14.6/100,000 and only 6% of the 494 cases in the 
elderly occurred among the residents ofLTCFs (Statistics Canada, 1993). 
TB in Health Care Employees 
TB infection has been considered an occupational risk for health care workers for 
many years (Amberson, 1936; Barrett-Conner, 1979; Bow, 1937; Daniel, 1948; 
Heimbeck, 1936; Levine, 1968). Daniel (1948) reported that, in a survey of over 5,000 
nurses, 80% of them had positive tests at the time of entry to the hospitals. Among those 
who initially had negative results, 54-80% converted to positive in the first year. The 
incidence of TB among all nurses was about twice that among control populations of the 
same sex and age. Bow (193 7) reported that the incidence of TB among Saskatchewan 
nursing students was 1.3%, 8 times greater than other students of the similar age. 
Amberson (1936) had similar results, finding a rate of 1.7% TB incidence in student 
nurses, nearly 6 times greater than other professional women with a 0.3% annual rate in 
the same age. 
For these high risk groups, it was found that TB incidence among persons with 
initial positive PPD tests was much lower than those with negative PPD tests. Heimbeck 
(1936) in Norway reported that, among 200 students who already had PPD positive 
reaction before the time of entry into nursing school, in a three years follow..;up, three 
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students developed active TB, a rate of 1.5%. Among the students who had negative 
results, 95% of them converted to positive and 48 of 220 (22%) developed active TB 
during 3 years of training. Hyge ( 194 7) had similar findings showing that 41 of 105 (59%) 
tuberculin skin test-negative students developed TB after exposure to an infectious 
teacher. Of 130 classmates who had tested positive before exposure to their infectious 
teacher, only 2 (1.5%) developed TB. These studies not only suggested that there were 
high exogenous infection rates in these students, they also showed that previous TB 
infection provided protection from re-infection. 
Since the 1980s, a number of studies have shown that health care workers have no 
increased risk of contracting TB (Aitken, 1987; Burrill et al, 1985; Raad et al, 1989). 
Aitken (1987) divided all hospitals in Washington State into three groups: those with no 
TB patients, those with smear-positive TB patients, and those with smear-negative TB 
patients being admitted. The conversion rate of employees in these three categories of 
hospitals was not significantly different in statistical terms and the conversion rate was not 
greater than the general population. 
Raad et al (1989) compared a psychiatric hospital without a known TB case with a 
general hospital that had admitted unsuspected TB cases. He found that the conversion 
rate of employees in both hospitals was not related to the number of unsuspected TB 
patients admitted but was proportional to the incidence of TB in their surrounding 
communities. It was also found that the majority of skin test convertors at the general 
hospital had little or no contact with patients. 
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Burrill (1985) and co-workers analyzed 11 years of data from British Columbia 
and found that the TB incidence in female nurses across all health settings was similar to 
that in other women after adjusting for age and birthplace. It was also reported that the 
nurses who had positive tuberculin skin tests were found to be 4 times as likely to contract 
active TB as the nurses having negative results when they started their training. This 
suggests that the likelihood of becoming infected with tubercle bacilli has diminished 
appreciably, and more TB comes from reactivation of remote infection than from 
exogenous infection. 
Tuberculosis and Birthplace 
As TB is still epidemic in some developing countries, immigrants from such areas 
may have a high infection rate before they come to the countries like Canada. Even if 
infection rate is low in the developed countries, these immigrants bring TB infection with 
them and tend to reactivate to active TB and have a greater TB incidence than the general 
population. Rosenberg and coworkers ( 1993) reported that the infection rate in foreign 
born nursing home employees is 42%, nearly 4 times that of Canadian born employees, 
who have a 12% infection rate. Burrill et al (1985) found that the TB incidence among 
nurses born in Asia was 12 times greater than other Canadian born nurses. It appears that 
the occurrence of the disease has more to do with the prevalence of TB in the country of 
origin than the place of current employment (Ashley, 1971 ; Berman, 1981 ; Price, 1987). 
The Social Determinants of Tuberculosis 
This review of the literature has covered the microbiological etiology of 
tuberculosis, the emergence of antibiotic therapies, the development of immunization 
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agents and their application as population screening tests, and the epidemiology of the 
disease irr terms of its distribution in populations around the world. 
While this review has described the vulnerability of specific populations to the 
disease, it has not done justice to the social and economic factors that have contributed to 
the emergence of the disease as a major cause of death in the world since early times, 
especially in the late 18th and early 19th centuries (McKeown, 1976, p 84), to the decline 
of the disease in the developed countries, to the continuing prevalence of the disease in the 
developing countries, and to the recrudescence of the disease in recent years in Western 
countries. 
The dramatic decline in mortality due to tuberculosis in England and Wales has 
been elegantly captured by McKeown in Figure 3, adapted from his book entitled "The 
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Modem Rise of Population" (1976). This figure clearly shows that the decline in mortality 
preceded the identification of the bacillus and the introduction of chemotherapy. Why this 
occurred is attributed by McKeown to the social and economic changes that resulted from 
the Industrial Revolution. These changes had a dramatic impact on the living 
circumstances of the former "peasantry" and even factory workers and miners were able to 
enjoy improved nutrition and better housing, water, and sanitation. These living 
circumstances, unsatisfactory as they might have been by modem standards, were the 
factors that contributed to the decline in mortality from tuberculosis over the decades. 
The relative contribution of chemotherapy and immunization has been at the "tail 
end" of decline and, while the contribution has been dramatic in reducing mortality and 
incidence of the disease, the gains have been at the margin after the social and economic 
factors had taken their effect (McKeown, 1976, p 101). 
It is perhaps ironic that it is those very same social and economic factors have 
begun to take their toll in this last decade of the twentieth century. The re-emergence of 
the disease is taking place among the groups and populations that share the living 
circumstances of people in the Western world 150 years ago. The gains that have been 
made in the living circumstances of the poor and marginalized appear now to be being lost 
as populations of homeless people emerge in an apparently affluent society that has failed 
to provide appropriate supports. Further, those who have had difficulty in making their 
way in a predominately white and western society such as blacks, Latin American and the 
aboriginal peoples find themselves further marginalized and trapped in unfavorable 
lifestyles that include the use of drugs, alcohol, cigarettes as well as inadequate nutrition 
I 
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and overcrowded housing (Barry et al, 1986; Bates, 1982; Crzybowski et al, 1987; Nardel et 
al, 1986). 
This has been further compounded in the modem world by the emergence of "new 
diseases" (such as HIV/AIDS) that compromise the immune system, leaving a foothold for 
tuberculosis. Inner city populations already vulnerable because of their living 
circumstances, now find themselves with rising incidence of HIV infection that in many 
cases will lead to death from tuberculosis. 
The social "safety net" that Canada has in place may have provided some 
protection from a replication of the increase in the incidence of TB in the US . But the 
country cannot be complacent since its vulnerable populations such as the aboriginal, the 
numbers of homeless (especially the elderly), the inner city problems of drug use, and 
continuing waves of immigrants from countries in which TB is still endemic, create a 
situation in which there will be an escalation in emergence of TB. The study reported in 
this thesis focuses on a vulnerable population, the staff of long term care facilities, and 
represents an attempt to not only to review a current monitoring program, but to restate 
the increased need for public health vigilance. 
I 
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CHAPTER V 
RESEARCH QUESTIONS, STUDY DESIGN, AND VARIABLES 
This chapter covers the research questions, subjects, sources of data, variables and 
analytical methods. It states the assumptions that have been made in analyzing the costs of 
British Columbia TB screening program in long-term care facilities (LTCFs). 
Research Questions 
formed: 
Based on the screening model described in Chapter ill, three research questions are 
1. Is TB incidence ofLTCF employees higher than that ofthe general 
population who are similar in age, gender and ethnic origins? 
2. Is TB infection rate ofLTCF employees higher than that found in 
similar studies in other jurisdictions? 
3. What are the costs of the screening program and how do these costs compare 
with the costs of treating active TB cases that would have occurred if the 
screening program had not been in place? 
Population Screened 
The population defined in this study is comprised of all L TCF employees who entered 
employment in British Columbia during the study time period from January 1, 1990 to 
December 31, 1994 (last complete data available). L TCF s refer to those facilities which are 
funded and licensed by the Department of Continuing Care. These facilities include both adult 
care and child care. 
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Sources ofData 
The medical records of each newly employed member and all ward admissions were 
downloaded from the Division of British Columbia TB Control database into four new files: 
demographics; tuberculin skin test; ward admissions; and chemoprophylaxis /active cases. The 
data were downloaded in ASCII format and converted to dBASE files for the purpose of 
analysis. 
Variables contained in file . For all the newly employed staff, the following variables 
were obtained: 
• population at risk type (adult vs. child care) 
• gender 
• birthday 
• birth country 
• aboriginal status 
• date of arrival in Canada 
• date of skin test administered 
• reaction of the skin test (mm) 
• date of skin test reading 
If the files showed that a screened employee had taken INH preventive therapy, the following 
variables were obtained: 
• reasons for starting INH preventive therapy 
• date of starting INH preventive therapy 
• date of stopping INH preventive therapy 
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• reasons for stopping INH preventive therapy 
• occurrence ofiNH-induced hepatitis 
• total days of taking INH preventive therapy 
For all active TB patients, the following variables were obtained: 
• date of diagnosis 
• methods of diagnosis 
• sites and types of active TB 
• treatment of active TB 
For all hospitalized TB patients, the following variables were extracted: 
• date of admission to hospitals 
• date of discharge from hospitals 
• total days of hospitalization 
Calculation of TB Infection and Incidence Rate 
TB infection rate. TB infection rate is calculated as the total number of positive PPD 
reactions, divided by the total number of employees screened in the study time period. 
TB incidence rate. To calculate the TB incidence rate, the numerator is the total 
number of TB cases that were reported in the study time period. The denominator is defined in 
term of "person-years" in order to capture the fact the population "at risk" is characterized by 
various lengths of employment. "Person-years" at risk was defined by using the number ofFTE 
employees of LCTF's during the period of study. The Department of Continuing Care, 
Ministry of Health stated that the number of employees expressed as full time equivalents 
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(FTEs) was 9,500, a figure that was in steady state during the five year study period. The 
figure of9,500 was multiplied by 5 to derive the "person years" at risk. 
Statistical Tests ofDifferences in Rates 
To test for the statistical differences in TB infection rates among various ethnic origins, 
between adult and child care employees, TB incidence rates between L TCF employees and 
British Columbia general population, chi-square (X2) statistical tests were used, and confidence 
intervals (CI) were calculated (Hennekens et al, 1987). 
Program Costs 
Unit Cost of screening program. The costs of the screening program were compiled 
based on the advice of Dr. John Farley, former Director of British Columbia TB Control 
Clinics. 
In the present study, only the direct costs of the medical procedures and tests related to 
the screening program were included. These costs encompass the following two components 
of the screening program: 
• screening cost: cost of tuberculin skin test and cost of chest X-ray 
• cost ofiNH preventive therapy including consultation, liver function tests 
(three times for the first three months), follow-up visits on a monthly basis (12 
months), and drugs (INH and B6 for 12 months). Since no INH-induced hepatitis 
occurred in the review of the employees files, costs associated with this side effect 
were excluded. 
The various cost elements are detailed in Table 6. 
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It needs to be emphasized that various overhead, indirect, and "opportunity costs" are 
not included in this cost analysis. Such costs include those associated with the administration 
and direction of the program, maintenance of data files, and employees' loss of time at work 
when attending for follow-up and treatment. The total costs attributed to the program in the 
present analysis is, therefore, conservative. 
Table 6 
Unit Costs For Screening And Routine Isoniazid Prophylaxis. 
Items costs$ 
Tuberculin skin testing 
Chest X-ray, PA and lateral 
7.65 
37.69 
INH preventive therapy 
Liver function tests 4.77 X 3 13.31 
(SGPT, SGOT, T.Bili) 
Medical consultation X 1 118.59 
Clinic costs per visit, 34.00 X 12 408.00 
Drug costs, for one year 
Isoniazid, 300mg, orally, daily 26.10 
Pyridoxine, 12.5 mg, orally, daily 6.06 
Subtotal 572.06 
Note: From "British Columbia Medical Service Fee Schedule" by Medical Service 
Commission, British Columbia, 1993 . 
Total Cost of Screening Program. The total cost of the tuberculin skin test screening 
program itself (i.e excluding the costs of treating TB cases) encompasses the initial screening 
costs to identifY possible cases and the costs ofiNH preventive therapy (Adhikari, 1995; Yuan, 
1995). 
( 1) Total cost of initial screening 
• total cost of PPD tests = number of employees screened multiplied by the unit 
cost of each PPD test 
• total cost ofX-rays =number of employees who have PPD positive reactions 
multiplied by the unit cost of chest X-ray 
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(2) Total costs oflNH preventive therapy 
• number of employees who take INH multiplied by the cost of treatment of one 
TB infection with INH. It should be noted that the number of employees taking 
INH includes all those who started an INH regimen, whether or not they 
completed the full course. No adjustment was made for the lower drug costs that 
would be incurred by "drop-outs" since the cost of clinical and chest X-ray 
follow-up would still be incurred. 
Estimation of Occurrence of Active TB from TB Infection 
The number of active TB cases prevented by INH preventive therapy is calculated based 
on the following assumptions: 
• for those who have PPD positive reactions but do not take INH preventive 
therapy, it is assumed that 5% will develop active TB in their lifetime (Stead, 
1995) 
• for those who take INH preventive therapy less than 6 months, INH protection 
is considered to be negligible (Grzybowski et al, 1976). Therefore, the same rate 
of the development of active TB as those who do not take INH is used for this 
group 
• for those who have PPD positive reactions and take more than 6 months ofiNH 
preventive therapy, 90% of those 5% who would otherwise have developed 
active TB will be prevented (CTS, 1996; Fitzgerald et al, 1990) 
Hence, the number of active TB cases prevented by INH is calculated as the number of 
persons who finish INH preventive therapy multiplied by 5% and 90%. 
The number of individuals finishing INH preventive therapy is calculated as the total 
number of individuals prescribed INH multiplied by the compliance rate. 
A Comparison of Current, Standard and Ideal Screening Programs 
As described above, the costs of the B. C. program under review are based on the total 
number of employees, the number of employees who have positive PPD reactions, the number 
of employees who take INH preventive therapy, and the actual compliance rate. 
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The costs of programs are also calculated for two additional scenarios, a "standard" 
program and "ideal" program. These programs are defined as follows. 
A standard program is defined as one in which the number ofLTCF employees with PPD 
positive reactions who proceed to take INH preventive therapy is based on the ATS/CDC 
(1986) recommendations and Stead's study (1985). 
According to ATS/CDC recommendations, individuals over 3 5 years old with other 
factors that increase the risk of developing active TB are recommended for INH preventive 
therapy. Based on Stead's report (1985), 14% of employees who are over 35 years old have 
other factors increasing their risk of developing active TB. Further, all those less than 35 years 
old with positive PPD reactions are recommended for INH preventive therapy. 
It is assumed that the compliance rate in the standard program is the same as in the 
current program. 
The costs of an ideal program is based on the assumptions of a standard program except 
that the compliance rate is assumed to be 100%. 
Costs for treatment of active TB 
In order to compare the cost of the screening program and the INH preventive therapy 
with the potential cost of the treatment of an active TB case that may have occurred if the 
screening program had not been in place, algorithms were constructed for the hypothetical 
costs of active TB treatment programs. 
The cost of treating an active TB case was calculated using an outpatient model, an 
inpatient model and the cost of follow-up of contacts for an index case. 
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Costs for treatment of outpatients. The costs include: routine chest X-rays (three times 
which occur at the beginning, middle and end of treatment), sputum smear, culture and 
antibiotic sensitivity (three times), baseline CBC, ESR and liver function tests (three times), 
medical consultation, follow-up clinical visits and drugs (INH, RMP and Pyridoxine for 9 
months, and Ethambutol for the first two months) (Table 7). 
Table 7 
Costs For Treatment Of An Outpatient During A Nine-Month Period 
Items 
Physical examinations and various tests 
Chest X-ray (PA and lateral) 37.69 X 3 
Sputum smear, culture , and sensitivity (39.02 X 3) 
Antibiotic sensitivity (13.16 X 3) 
CBC,ESR 
Liver function tests (4.77 X 3) 
Medical consultation 
Clinical visit monthly, 34.00 X 9 
Drug cost 
Total 
Isoniazid, 300mg daily X 9 months 
Rifampin , 600mg daily X 9 months 
Ethambutol, 1 ,200mg orally, daily X 2 months 
Pyridoxine, 12.5mg, orally, daily X 9 months 
Costs 
113.07 
117.06 
39.48 
17.36 
14.31 
118.59 
306.00 
19.31 
380.65 
56.41 
4.48 
1186.72 
Costs for inpatients. The major costs of hospitalized patients include hospitalization and 
daily physician visits. According to the Division of Tuberculosis Control data (1994), the 
average length of hospitalization is 29 days. The per diem cost of hospitalization are stated to 
be $575 .00, a figure that includes "hotel" costs and routine drug and testing costs. Since other 
tests, such as gastric washing, sputum induction and fiberoptic bronchoscope, are not routinely 
performed, charges for these procedures have not been included. 
Table 8 
Maior Costs For Treatment Of A Hospitalized Patient For 29 Days 
Items 
Hospitalization for 29 days, $575.00/day 
Daily medical visit for 29 days, $21 .62/visit 
Total 
Costs 
16675.00 
626.98 
17301 .98 
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Costs for follow-up of contacts with an index case. These costs include those related to 
the testing of contacts, the initiation ofiNH preventive therapy, and the treatment of contacts if 
they develop active TB. According to Fitzgerald et al (1990), each contact requires two 
physician evaluations, two clinical visits, and one tuberculin skin test. Based on national data 
from the United States, each index case precipitates 6.56 contacts who are given a tuberculin 
skin test, 1.5 chest X-rays are performed on infected contacts, and INH preventive therapy is 
administered for one year to 0.8 contacts. Each case also results in 0.06 additional cases 
requiring treatment (Snider et al, 1986). The calculations of costs for clinical examinations and 
treatment of contacts are listed in Table 9. 
Table 9 
Costs for follow-up of contacts with index case 
Items 
Physician costs per contact (2 X 34.00) $68.00 
Clinic costs per visit ($21 .62 X 2) $43.24 
Mantoux skin test $7.65 
Subtotal $119.89 
6.50 contacts/case (6 .6 X 119.89) 
1.5 chest X-rays/case ($37.69 X 1.5) 
0.8 INH preventive therapy administered 
0.06 new cases of TB treated 
Total 
Cost 
779.29 
56.54 
457.65 
557.36 
1850.84 
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Total cost of treatment of an active TB case. The total costs of treatment of a patient 
without hospitalization include the cost of treatment as an outpatient ($1 , 186. 72) and the cost 
offollow-up of contact cases ($1,850.84) as shown in Table 7 and Table 9, respectively. 
The total cost for a TB patient treated in an outpatient basis, therefore, is $3,037.56. 
The total costs for treatment of a patient with 29 days of hospitalization include the cost 
of hospitalization ($17,301.98) and the cost of follow-up of contact cases ($1 ,850.84) as 
shown in Table 8 and Table 9, respectively. Since hospitalized patients continue their treatment 
on an outpatient basis after discharge, it is necessary to add in the costs of the out-patient 
treatment as shown in Table 7. These costs have not been adjusted for the tests and drugs that 
may have been administered in the hospital stay. 
The total cost for a hospitalized patient is, therefore, $20,339.54. 
Average cost for treatment of an active TB case. In order to arrive at an average cost 
for a patient treated for TB, "weighted " for whether the patient is hospitalized or not, the 
hospitalization experience of B.C. was used. These costs again do not include indirect and 
opportunity costs. According to B.C. TB Control (1994), 42% of active TB patients are 
hospitalized with the remaining 58% treated on an outpatient basis. Using the total costs 
attributed to hospitalized and outpatient patients respectively, the weighted cost for the 
treatment of a TB patient is calculated as follows: 
(58%x$3,037.56)+(42%x$20,339.54)= $10,304.39. 
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CHAPTER VI 
RESULTS: TB INFECTION AND INCIDENCE RATES IN LTCF EMPLOYEES 
In this chapter, the demograpic characteristics, TB infection and incidence rates among 
LTCF employees in the period 1990-94 are presented. These rates are compared among 
foreign born, First Nations and other Canadian born individuals and also between adult and 
child care facilities. 
The actual incidence ofTB in British Columbia and in LTCFs in the province is included 
in this chapter. 
The infection rates tabulated in this chapter are used as the basis for the calculation of the 
costs of the screening program, the follow-up treatment with INH, and treatment of TB cases. 
The results of these calculations are shown in Chapter VII. 
The Demographic Characteristics of the Screened Population 
Between January 1, 1990 and December 31 , 1994, 17,571 individuals started to work in 
British Column LTCFs. Among them, 49 did not have pre-employment tuberculin skin tests 
and 544 had tests but no result recorded in the files. Gender or/and country of birth were 
missing in the files of other 392 individuals. These subjects are excluded from this study. 
Totally, 16,586 complete records were available for analysis. 
The demographic characteristics ofthe screened populations are summarized in Table 10. 
For all screened employees, the mean age is 35 years, with a standard deviation of 11 (M=35, 
SD =11). The gender proportion of female to male employees across all the groups is 5 to 1, 
approximately. Among the different ethnic groups, the age proportions are similar, the mean 
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age in foreign born individuals is 38 with standard deviation (SD) of 11 , First Nations 36, with 
SD of 11 , and Canadian born 34 with SD of 11 . 
Table 10 
The Demographic Characteristics Of The Screened Employees 
Foreign First Canadian Total 
Born Nations Born 
Number of Female Employees 3,707 178 9,871 13,756 
Number of Male Employees 730 27 2,073 2,830 
Total Number of Employees 4,437 205 11,944 16,586 
Mean Age & (SD) 38(11) 36(11) 34(11) 35(11) 
TB Infection Rate 
The results showed that 3,657 subjects have positive reactions, and the overall infection 
rate is 21 . ~/o (Table 11 ). In the different ethnic groups, however, the rates vary. 
Table 11 
The Infection Rate Among Different Ethnic Groups (Crude And Adjusted Rate) 
Number of Number of PPD Crude Adjusted Adjusted 95% Cl 
em~lo~ees Positive Rate{%} Rate{%} RR* 
Canadian born 11 ,944** 1,243 10.6 14.6 1 
Foreign born 4,437 2,319 52.3 49.7 3.4 3.23-3.58 
First Nations 205 95 46.3 43.8 3.0 2.49-3.61 
Total 16,586 3,657 21.9 25.5 1.74 1.65-1.84 
*RR stands for relative risk. 
**include 381 subjects who were born in the United States of America. 
Foreign born and First Nations individuals, respectively, have 5 and 4.5 times greater infection 
rate than Canadian born. Direct age and gender standardization based on 1991 census of 
British Columbia was carried out. The rates in foreign born (RR=3.4, 95% CI is [3 .23-3.58]) 
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and First Nations individuals (RR=3 .0, 95% CI is [2.49-3.61]) were significantly greater than 
that of Canadian born. 
-~ 
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The infection rate among each age and ethnic group is shown in Figure 4. 
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For all employees, the infection rate increases with age. For foreign born individuals, the 
infection rate increases with age until the 35-44 age group when the infection rate becomes 
stable. This pattern is complicated, since many factors affect PPD tests, such as BCG 
vaccination status, immigration date and country of origin (Adhikari et al, 1995; Yuan et al, 
1995). For First Nations persons, the infection pattern is similar to foreign born, but the sample 
size is small and may not be reliable. For Canadian born individuals, the infection rate increases 
with age until 64 years of age, with a drop after 65, since individuals over 65 may revert to 
negative reactions (Stead, 1987). 
Foreign born individuals were classified into 5 subgroups based on geographic areas 
of origin (Table 12): Africa; Asia-Oceania; Latin America (South and Central America); 
Table 12 
The Crude And Adjusted Infection Rate Among Foreign Born Groups 
Number of Number of PPD CrudeR.(%) Adjusted RR* 95% Cl 
Em~lo~ees Positive 
Africa 190 96 50.5 3.24 2.69-3.90 
Latin America 301 180 59.8 2.86 2.44-3.35 
Asia & Oceania 2,004 1,171 58.4 3.91 3.68-4.16 
Eastern Europe 416 291 70.0 4.31 3.86-4.81 
Western Europe 1,526 581 38.1 2.60 2.37-2.85 
Total 4,437 2,319 52.3 3.40 3.23-3.58 
* the RRs were calculated based on the Canadian born. 
Western Europe, and Eastern Europe. Western Europe was defined as the United Kingdom, 
Ireland, Iceland, Denmark, Norway, Sweden, Germany, Netherlands, Belgium, France, 
Switzerland, Greece, Italy, Spain and Portugal. All other European countries were defined as 
Eastern Europe. Immigrants as a whole have significantly greater infection rate (52.3%, 95% 
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CI is [3.23-3 .58]) than Canadian born individuals, and each subgroup also has a higher 
infection rate when compared to the Canadian born individuals. The infection rates, however, 
are different among the different origins. Immigrants from Western Europe (38.1%, 95% CI is 
[2.37-2.85]) have the lowest infection rate, but those from Eastern Europe (70.0%, 95% CI is 
[3 .86-4.81]) have the highest infection rate in all the immigrant groups. 
The comparison of TB infection rate between child care facility employees and adult care 
facility employees is shown in Table 13. TB infection rate in child care facility employees is 
lower than adult care facility employees. After adjusting for age, gender and ethnic origin, 
however, child care facility employees do not have significantly lower infection rate (RR = 
0.93, 95% CI is [0.87-1.0]) than adult care facility employees. 
Table 13 
The ComQarison Of TB Infection Rate 
Between Adult Care And Child Care Facility EmQloyees 
Number of Number of Rate Adjulted Adjusted 95%CI 
tests positive reactions (%) rate RR 
Adult care 10,516 2,587 24.6 24.6 
Child care 6,070 1,070 17.6 22.9 0.93 0.87-1.0 
Total 16,586 3,657 21.9 
TB Incidence Rate 
Between 1990 and 1994, 1,574 active TB cases were diagnosed in British Columbia. Of 
these, 5 occurred in L TCF employees. The incidence of TB in L TCF employees is shown in 
Table 14. The crude TB incidence in LTCF employees and the general population is 
10.5/100,000 and 9.6/100,000 respectively. There is no significant difference between these 
two rates (RR = 1.1, 95% CI is [0.46-2.64]). For a more accurate comparison, indirect 
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standardization was used based on the 1991 census of British Columbia population. After 
adjustment for age, gender and birthplace, there is still no significant difference in these two 
groups (RR = 1.03, 95% CI is [0.40-2.32]). 
Table 14 
TB Incidence Rate Among LTCF Employees And Community Individuals 
(Crude And Adjusted Rates) 
Person- Number Rate Crude 95% Cl Adjusted 
years ofTB (1/100,000) RR RR 
L TCF employees 47,500 5 10.5 1.1 0.46-2.64 1.03 
General population 16,362,850 1,569 9.6 1 1 
Total 16,410,350 1,574 9.6 
95% Cl 
0.40-2.32 
TB incidence in each ethnic group was also calculated (Table 15). Although foreign 
Table 15 
The comparison of TB incidence among different ethnic groups 
Community population L TCF employees 
Person- Number Rate Person- Number Rate Crude RR 
years of cases (111 00,000) years of cases (1/100,000) 
Foreign born 3,615,850 882 24.4 13,999 3 21 .4 0.88 
First Nations 520,030 260 50 613 163 3.26 
Other Canadians 12,274,470 340 2.8 32,888 1 3 1.07 
Total 16,410,350 1,574 9.6 47,500 5 10.5 1.09 
born and First Nations employees together represented 28% of the population, they accounted 
for 80% of the total TB cases. The TB incidence in foreign born and First Nations persons are 
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7 and 54 times, respectively, greater than Canadian born. The relative risk of TB in foreign 
born employees to foreign born community individuals, First Nations employees to First 
Nations community individuals and Canadian born employees to Canadian born community 
individuals are 0.88, 3.26 and 1.07, respectively. These results must be interpreted with 
caution, since the number of cases in each subgroup is small. 
TB incidence rate in adult care and child care facility employees is shown in Table 16. TB 
incidence of adult care (10.1/100,000) is similar to the rate of child care facility employees 
(11.311 00,000), which implies that TB transmission in adult care is negligible. However, as the 
sample is small, no statistical analysis was carried out. 
Table 16 
TB Incidence Rate In Adult And Child Care facility emnloyees 
Person-years Number of TB cases Rate (1/100,000) Crude RR 
Adult care 29,871 3 10.1 1 
Child care 17,719 2 11.3 1.1 
Total 47,500 5 10.5 
Of the 5 TB cases in the LTCFs, 2 of them are pulmonary TB (40%) and 3 are extra-
pulmonary TB ( 60% ). The pulmonary TB rate in the LTCF employees is one-half of the 
general population, which has a rate of 70-75% (Division of TB Control, 1994). Since 
pulmonary TB is more infectious than extra-pulmonary, from this aspect, the risk of TB 
transmission in the LTCFs is lower than the general population. Further, the sputum smears of 
all 5 TB cases in L TCF employees are negative, only one case has a positive culture, 
reinforcing the conclusion that the risk ofTB transmission is not significant. 
CHAPTER VII 
RESULTS: COSTS AND COST IMPLICATIONS OF THE TB SCREENING 
PROGRAM IN LTCFS IN BRITISH COLUMBIA 
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In this chapter, the costs of the screening program, the follow-up treatment with INH, 
and the treatment of TB cases are calculated. The costs of the actual, 'Mandard," and 'ideal" 
programs are compared. 
The Outcome of the Screening Program 
As shown in Chapter VI, 3,657 employees were recorded as having positive PPD 
reactions in the five years 1990 - 94. Of this number, 236 (6.5%) were prescribed INH 
preventive therapy to prevent occurrence of active TB from TB infection. 
At the time that the data were obtained, sufficient time had not elapsed for 57 cases 
who had begun INH therapy in 1994 to complete their course of treatment. For this reason, the 
compliance rate was based on the experience of 1990-93 with the assumption that the 
compliance rate for the 1994 cases would have been similar. 
Compliance rate: Between 1990 and 1993, 179 employees were administered INH 
preventive therapy and 115 finished the treatment, giving a compliance rate of 64% (115/179). 
The compliance rate varies, however, by diagnostic status as shown in Table 17. Individuals 
who had inactive TB have the greatest compliance rate (100%). The contacts who had positive 
PPD reactions had the lowest rate (40%). 
The reasons for non-compliance as recorded in the files are shown Table 18. It was 
found that 36% stopped taking the drug because of drug reactions. Twenty-two percent did 
not co-operate with treatment and another 34% stopped taking INH for unknown reasons. 
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Table 17 
The Comparison Of Compliance Rate Among Various Candidates 
For Preventive Therapy ( 1990-1993) 
Reason for preventive therapy 
Inactive TB 
Contact and PPD positive 
Convertor 
PPD positive 
Misdiagnosis 
TB with chest X-ray change 
PPD positive with HIV 
positive 
Total 
Table 18 
Number of 
prescribed 
11 
5 
20 
129 
1 
12 
1 
179 
Number of 
finished 
11 
2 
15 
79 
0 
7 
1 
115 
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Compliance rate 
(%) 
100. 
40 
75 
61 
0 
58 
100 
64 
The Various Factors of Causing Incomplete INH Preventive Therapy (1990-1993) 
Reasons Number Rate (%) 
Lost follow-up 1 2 
Not co-operative 14 22 
Drug reaction 23 36 
Left province 4 6 
Not known 22 34 
Total 64 100 
The Actual Costs ofBritish Columbia TB Screening Program 
The total costs of the British Columbia screening program were calculated using the 
costs of the various tests, procedures and drugs as shown in Chapter V applied to the number 
of employees screened, the number of employees who had positive PPD reactions, and the 
number of employees who took INH preventive therapy. The following process represents the 
detailed calculation of the various costs. 
Total costs of the screening program 
(1) total cost oftuberculin skin test : 
$7.65 x 16,386 (number of complete tests)= $125,353 
(2) cost of chest X-ray: 
$37.69 x 3,657 (number of positive PPD) = 
(3) total screening cost: (1)+(2)= 
( 4) total cost ofiNH preventive therapy: 
$145,146 
$263,185 
$572.06 x 236 (number prescribed INH) $135,006 
(5) total cost ofthe screening program: (3) + (4) = $398,191 
Number of Cases Prevented by the Screening Program 
( 6) Number of employees completing INH therapy: 
236 x compliance rate of64%= 151 
(7) number of active TB cases prevented: 
(a) 151 x 5% (estimated rate ofTB occurrence)= 7.55 
(b) 7.55 x 90% (estimated rate of protection by INH) = 7 
Costs attributed to the Prevention of One TB Case 
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These total costs of the program provide the basis for calculating the costs that can be 
attributed to the prevention of a case of TB occurring in this screened population using 
assumptions detailed in Chapter V (pp. 38) 
(8) screening cost for preventing one TB case: 
screening cost/number ofTB cases prevented = $263,185/ 7 = $38,732 
(9) cost ofiNH preventive therapy for preventing one TB case: 
INH therapy cost/TB cases prevented= $135,006.16 I 7 = $19,868 
r 
(I 0) total cost for preventing one TB case: 
total cost of screening progra.m!fB cases prevented = $398,191 I 7 = $58,600 
The above results have been summarized in Table 19. 
Table 19 
The Cost of TB Screening Program in the Current Program 
Items 
Cost of tuberculin skin test 
Cost of chest X-ray 
Total screening cost 
Cost of INH preventive therapy 
Total costs of the program 
Number of employees completed INH 
Number of TB case prevented 
Screening cost for preventing one TB case 
Cost of INH preventive therapy for preventing 
one TB case 
Total cost for preventing one TB case · 
Costs/Results 
$125,353 
$145,146 
$263,185 
$135,006 
$398,191 
151 
7 
$38,732 
$19,868 
$58,600 
Comparison of the Cost ofPreventing One Case with the Cost of Treating One Case ofTB 
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While the total cost of preventing one case of active TB based on the cost figures that 
have been attached the B.C. program and the 'Yield" of bringing cases to preventive INH 
therapy is $58,600, the cost of treating one active case of TB was shown to be $10,304 
('weighted" cost based on hospital and outpatient treatment) as shown in Chapter V(pp.42) .. 
Calculation of the Costs of Standard and Ideal Programs 
As described in Chapter V, a standard program assumes that the number of 
employees taking INH preventive therapy will be based on the ATS/CDC (1986) 
recommendations and Stead' s study (1985). These assumptions are applied to the outcome of 
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the B. C. screening program. Table 20 shows that the number of candidates who would be 
eligible under these assumptions would be 1,545. 
Table 20 
Number of INH Candidates in the Standard Program 
Age Number of PPD number of INH 
(years) positive candidates 
<35 1201 1201 
~35 2456 2456 x14%=344 
Total 3657 1545 
Assuming that 1,545 cases begin INH therapy, that the compliance rate of 64% found in 
the B. C. experience applies, and using the cost figures of the B. C. program, Table 21 shows 
that the costs of preventing one TB case are $5,915 for screening and $19,863 for INH therapy 
in the standard program. The cost of INH therapy is three times greater than the screening 
cost. However, the total cost of preventing one case is $25,778. When comparing to the actual 
program, increasing number ofiNH candidates decreases the costs for preventing one TB case. 
Table 21 
The Cost of TB Screening Program Calculated In Standard and Ideal Programs 
Standard Ideal 
Items 
Cost of tuberculin skin test 
Cost of chest X-ray 
Total screening cost 
Cost of INH preventive therapy 
Total costs of the screening program 
Number of employees finished INH 
Number of TB cases prevented 
Screening cost for preventing one TB case 
Cost of INH preventive therapy for preventing 
one TB case 
Total cost for preventing one TB case 
Condition 
125,353 
145,146 
$263,185 
$883,833 
$1,147,018 
989 
45 
$5,915 
$19,863 
$25,778 
Condition 
125,353 
145,146 
$263,185 
$883,833 
$1,154,332 
1,545 
70 
$3,785 
$12,712 
$16,497 
I 
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When the calculations are expanded to the ideal program in which it is assumed that the 
compliance rate is 100%, the screening cost for preventing one TB case is $3, 785; the cost of 
INH preventive therapy for preventing one TB case is $12,712, nearly 4 times greater than the 
screening cost. The total cost for preventing one case ($16,497) is 1.5 times more than the cost 
of treatment of one active TB case. Compared to the standard program, the increasing 
compliance rate decreases the screening cost and the cost of INH preventive therapy for 
preventing one active TB case, and the total cost of this program for preventing each active TB 
case decreases. 
However, while the data from the ideal program emphasize the impact that compliance 
has on unit costs, it is unrealistic to expect that 100% compliance can be achieved since INH 
side-effects are a significant cause for cessation of therapy. In the present study of LTCF 
employees, 36% of cases dropped out because of drug reactions, while the Division of 
Tuberculosis Control (1994) reports 14 %with drug reactions in its treatment of cases in the 
general population. 
The comparisons among the current, standard and ideal programs imply that: 
(a) to reduce the cost of preventing active TB cases, more employees who have 
positive PPD reactions should be encouraged to take INH preventive therapy. 
(b) the compliance rate ofiNH preventive therapy should be stressed. 
--
CHAPTER VIII 
DISCUSSION AND RECOMMENDATIONS 
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The purpose of the present study was to review the British Columbia TB screening 
program in long-term care facility (LTCF) employees based on 5 years of data (from 
January 1, 1990 to December 31 , 1994). In this Chapter, the findings showed in Chapter 
VI & VII are discussed and interpreted. Specifically, TB infection rate, the use of INH 
preventive therapy and TB incidence rate are dicussed and related to findings in other 
jurisdictions. The cost of this screening program compared to the outcome of the 
screening program are discussed. Finally, policy recommendations and future studies are 
suggested. 
British Columbia TB Database and Its Limitations 
Since the reporting of TB infection and disease is mandatory and screening is done 
only by the Division of TB Control, the British Columbia TB Control database represents 
a record of all PPD tests and all diagnosed TB cases in British Columbia. 
The large size of the population of L TCF employees screened in the present study 
provides a basis for a reliable estimate of the TB infection rate in this population and for 
the comparisons of rates among various subgroups. When the TB incidence rate is 
calculated and compared for each subgroup in the population, however, the numbers are 
small precluding standardization and statistical analysis. 
In the present study, less than 6% (985/17571) of cases had one or more missing 
variables and were deleted for the purpose of analysis. Since there is no reason to believe 
-
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that these cases are different than the population from which they are drawn, it is not 
believed that any bias has been introduced. 
Discussion of TB Infection Rate 
Screening methods and PPD results. In British Columbia, the one-step tuberculin 
skin test is used for screening. However, the two-step skin test is also used in some 
jurisdictions, as recommended by the American Geriatrics Society (1988). Different 
screening methods may affect the results. The two-step test produces 6% more positive 
reactions than the one-step tuberculin skin test (Rosenberg et al, 1993). However, false-
positive reactions may also be observed in persons infected with nontuberculous 
mycobacteria or vaccinated with BCG (Rosenberg et al, 1993; Thompson et al, 1979). A 
comparison of the observed British Columbia rates of TB infection with other 
jurisdictions, therefore, should be made cautiously. 
Overall TB infection rate. TB infection rate of 21 .9% among British Columbia 
LTCF employees is in the mid-range of the 4.6-47% reported in the literature (Barry, 
1987; Bass, 1981 ; Brennen, 1988; Gross, 1986; Halperin, 1992; Price, 1987; Rosenberg et 
al, 1993; Simon, 1983; Thompson et al, 1979; Valenti, 1982; Welty, 1985). This wide 
range of reported TB infection rates is related to variance in ethnic composition, age and 
gender in the population screened and to the methods of screening used. In general, the 
higher the percentage of immigrants from countries where TB is still epidemic, and the 
more recent the immigration, the higher the infection rate. Rosenberg et al (1993) studied 
nursing home employees in Manitoba and found that foreign born subjects were more than 
twice as likely to have tuberculin skin test positive reactions as Canadian born subjects 
58 
(60%, 95% CI is [2.5-11.4]). Also, a tuberculin skin test positive reaction is inversely 
· related to the duration of time elapsed since arrival in Canada (Menzies et al, 1992; 
Rosenberg et al, 1993). The older the population, the higher the infection rate. It has also 
been found that the higher proportion of males in the population, the higher the infection 
rates, although the reason for this is not clear (Gerald et al, 1990). 
TB infection in Canadian born employees. The infection rate in the Canadian born 
employees of 10.6% was shown to be significantly lower than foreign born (52.3%) and 
First Nations (46.3%). The infection rate in Canadian born individuals increases with age 
to 64 years old and then drops, consistent with Stead' s finding (Stead, 1987). It is 
probable that lower cell-mediated immune status among the elderly contributes to a higher 
false-negative reaction rate. For comparison, TB infection rate in Canadian born 
employees in British Columbia LTCFs is lower than the study in Manitoba with rate of 
23 .8% (Rosenberg et al, 1993 ). This may be explained partly by the age difference 
between these two populations. The mean ages in British Columbia and Manitoba L TCF 
employees are, respectively, 35 (SD=11) and 41(SD=13). The difference can also be 
attributed to the small sample size (n=126) and its an urban population in the Manitoba 
study, which had a higher infection rate (Gerald et al, 1990). 
TB infection in First Nations employees. Among the First Nations employees, the 
overall infection rate is 46.3%. It is believed that they have a high infection rate because 
they were not exposed to TB until contact with settlers from the Old World and the 
population has not yet developed a strong immune status. As a result, TB is epidemic in 
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this population (Gerald et al, 1990). Further, BCG vaccination is widely used in this 
population and may overestimate the infection rate. 
TB infection in foreign born employees. In foreign born group, immigrants 
(52.3%) from different parts of the world have a significantly greater TB infection rate 
than Canadian born individuals (10.6%). These differences are related to the TB infection 
and incidence rates in the countries of origin (Menzies, 1992). These differences are also 
dependent on age, immigration time and whether or not BCG vaccination has been 
administered. It has been reported that the younger the immigrants come to Canada, the 
lower the infection rate (Menzies, 1992). If age is constant, the longer they stay in 
Canada, the lower the infection rate, representing either waning immune memory or the 
death of residual tubercle bacilli from remote infection (Stead et al, 1987). 
As discussed in Chapter I, since BCG vaccination and non-mycobacterium 
infection may cause false-positive reaction of PPD test, the high rate of BCG vaccination 
and the high non-mycobacterium infection rate in some developing countries may 
overestimate the TB infection rate in these groups. 
For comparison, TB infection rate in the immigrant group in the present study is 
also in the mid-range of 32-80% reported in other studies (Blum, 1993; Menzies, 1992; 
Nolan, 1988; Passes, 1982; Quillan, 1990). 
Comparison of TB infection rate between adult and child care facility employees. 
When the TB infection rate between adult care and child care facility employees is 
compared, it is found that the adult care facility employees have a higher infection rate 
(24.6%) than the child care (17.6%). However, after adjusting for age, gender and ethnic 
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origin, the difference is not significant (RR=0.93 , 95% CI is [0.87-1.0]). This supports the 
conclusion that employees working in the adult care facilities are not at increased risk of 
TB infection compared to the child care employees. 
Discussion of TB Incidence Rate 
It was calculated that the TB incidence rate in LTCF employees (10.5/100,000) is 
not greater (RR = 1.03, 95% CI is [0.40-2.32]) than the general population (9.6/100,000). 
This can be interpreted to mean that the L TCF employees are not at higher risk than the 
general population of developing active TB. Second, TB incidence in adult care facilities 
(10.1/100,000) is similar to the rate in child care facilities employees (11.3/100,000). This 
implies that neither residents of adult care facilities have greater risk of transmission of TB 
to the employees nor employees of adult care facilities have greater risk of transmission of 
TB to the residents than the child care facilities . Third, it was also found that the TB 
incidence rate is more related to the country of origin and ethnic groups than where they 
are working. The incidence rates in foreign born and First Nations individuals are, 
respectively, 7 and 42 times higher than other Canadian born individuals. Fourth, TB 
incidence in each ethnic group is consistent with its corresponding general population. The 
relative risk of TB in foreign born employees to foreign born community individuals, First 
Nations employees to First Nations community individuals and Canadian born employees 
to Canadian born community individuals are 0.88, 3.26 and 1.07, respectively. These 
results also indicate that TB is more related to the country of birth rather than place of 
employment (Ashley, 1971 ; Berman, 1981 ; Price, 1987). 
·-· 
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It should be noted that in this study TB incidence rate in L TCF residents was not 
calculated, further research is needed to evaluate the TB incidence in L TCF residents and 
the relationship with that ofLTCF employees. 
INH Preventive Therapy 
INH preventive therapy was administered to those persons who had positive PPD 
reactions in order to prevent occurrence of active TB. Of 3,657 employees who had 
positive PPD reactions, 6.5% (236) were prescribed INH. This rate of prescription ofiNH 
is much lower than the CDC/ATS recommendations (CDC/ATS, 1986). Based on these 
recommendations and Stead' s study (1985), it was calculated that 42.2% (1 ,545/3 ,657) 
should take INH. The reasons for the low INH administration rate in the British Columbia 
screening program attributed by the former director ofTB Control clinics, Dr. John Farley 
(personal communication, November, 1996) to the following factors : 
• the patients' unwillingness to take INH, since they feel they are healthy and do 
not need treatment 
• the long-term treatment (12-month on daily basis) ofiNH preventive therapy 
requires a substantial commitment that may be difficult to make 
• doctors may be reluctant to prescribe INH preventive therapy because of the 
potential side effects of INH 
Of 236 employees who began to take INH, 64% completed the treatment. The 
compliance rate appears to be related to the status of TB infection. Patients with inactive 
TB and TB infection with positive HIV had 100% compliance rates reflecting their 
expected annual risk of developing TB of 1 in 190 and 1 in 12 respectively (Ministry of 
r--- ·-, 
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Health, 1991 ). The lowest rate ( 40%) was found in contacts with positive reactions, a 
group that a low risk of developing active TB (5% for a lifetime). 
Among the individuals who did not finish INH, 22% did not comply with the 
treatment and another 36% with unknown reasons were lost to follow up. The results 
suggested that enhanced follow up of INH preventive therapy may be needed to improve 
the compliance rate. 
Analysis ofProgram Costs 
As it was discussed in Chapter V, the costs ofthe screening program was based on 
the medical procedures and various tests (e.g., cost of tuberculin skin testing, chest X-ray, 
various lab tests and drug treatment). Indirect costs such as those associated with the 
administration and direction of the program, maintenance of data files, and employees' loss of 
time at work when attending for follow-up and treatment were not included. If the indirect 
cost is included, the costs of screening program and treatment of active TB patients would 
be increased. Specially, the "opportunity" costs for inpatients would be increased 
dramatically. Hence, the cost gap between the screening program and treatment of active 
TB cases is narrower than shown in the present study. 
Further, the assumptions made about the lifetime risk of TB and the protection rate 
of INH affect the costs attached to the outcome of TB screening program. In the present 
study, 5% ofTB occurrence oflifetime risk among those who have positive PPD reactions 
without INH and 90% INH protection to those who finished INH preventive therapy were 
used. In fact, for estimation of lifetime risk of TB, the reported range was between 0.9% 
and 10% (Comstock, 1975; CTS, 1994; Kopanoff, 1978; Tsevat, 1988). However, it is 
-
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widely stated that, if not treated, 5% of tuberculin converters will develop active TB 
within 1 or 2 years and that another 5% will develop it later in life (Stead, 1995). For the 
British Columbia TB screening program, only a one-step test is administered and no 
further tests are required, so a positive reaction of the tuberculin skin test is defined as a 
reactor not as a convertor. It is therefore reasonable to use 5% estimation. The ninety 
percent of INH protection which was used in calculation is in the mid-range of the 70-
1 00% reported in the other studies, and is consistent with the CTS recommendation rate 
(CTS, 1996). However, different estimations of lifetime risk of TB and INH protection 
rate would affect the cost of TB screening program. The higher the estimation of lifetime 
risk of developing active TB from TB infection and the higher the INH protection rate 
used, the less the cost for preventing one case of active TB in the screening program. 
Costs and Benefits 
It was calculated that $58,600 was spent to prevent one active TB. If he/she were 
not screened and administered INH preventive therapy, the cost of treatment of one active 
TB case, on average, would have been $10,304. 
When the costs of the actual program is expanded to hypothetical standard and 
ideal programs, the costs of these screening programs for preventing one TB case 
($25,778 and 16,497, respectively) are lower than the actual program. These results 
showed that increasing number of employees with positive PPD reactions taking INH and 
increasing compliance rate reduce the cost of preventing each active TB case. 
Although this study was not intended to be a full cost efficiency or cost benefit 
analysis, the dramatic cost difference between the screening program and the treatment of 
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active TB cases that are potentially prevented supports that, at first sight, the program is 
not cost effective. But the method used to calculate costs were based only on direct 
screening, medical costs, future work is needed to expand this research into a cost 
effective/cost benefit study. 
Nevertheless, taking another approach, MacArthur ( 1992) reported that a common 
rule of thumb in TB screening program is that screening is cost-efficient when the disease 
incidence is greater than 100/100,000 people. Given a 10.5/100,000 TB incidence rate in 
British Columbia LTCF employees, it would need a ten-fold increase in TB incidence in 
this population to satisfy this screening criterion. 
While the low incidence rates of TB infection and disease in this population and 
the cost of the screening program suggest that the program may not be currently justified, 
the ethnic heterogeneity of the L TCF employee population with TB infection rates of 
52.3% and 46.3%, and incidence rates of21.4/100,000 and 163/100,000 for foreign born 
and First Nations, respectively, there appears to be a need for sustained vigilance 
particularly in these two subgroups. 
Recommendations and Policy 
1. The data related to the rate of TB infection, the incidence of TB disease and the 
costs of the screening program as calculated in the present study strongly indicate 
that the Division of British Columbia TB Control should consider whether the 
present screening program should be continued. 
2. The data suggest that it would be more cost effective to limit the screening the high 
risk groups which were identified in this study as First Nations and immigrants 
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within the larger population. 
3. Comparing the low rate (6.5%) of prescription ofiNH to those who had positive 
PPD reactions in the screening program with the rate ( 42.2%) calculated base on the 
CDC/ATS recommendations (CDC/ATS, 1986) and Stead' s study (1985), the 
recommendations from ATS/CDC and CTS (1996) should be followed to increase 
the effectiveness of the screening program. 
4. Considering the reasons of stopping INH preventive therapy, 21.9% did not 
comply with the treatment and another 36% with unknown reasons were lost to 
follow up, enhanced follow up programs are required to increase the 
compliance rate. 
Future Research 
1. A cost effective /cost benefit analysis should be conducted to evaluate the 
tuberculin skin test screening program. Direct and indirect costs should be 
included. 
2. Although it is impossible to calculate TB infection rate for L TCF residents. since 
chest X-ray screening program is mainly performed in this group, TB incidence 
should be investigated and compared to the surrounding communities. 
3. A cost of chest X-ray screening program should also be evaluated. 
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